• Je něco špatně v tomto záznamu ?

Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology

E. Boisteau, C. Posseme, F. Di Modugno, J. Edeline, C. Coulouarn, R. Hrstka, A. Martisova, F. Delom, X. Treton, LA. Eriksson, E. Chevet, A. Lièvre, E. Ogier-Denis

. 2022 ; 41 (42) : 4673-4685. [pub] 20220906

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033170
E-zdroje Online Plný text

NLK ProQuest Central od 2000-01-01 do Před 1 rokem
Open Access Digital Library od 1997-01-01
Health & Medicine (ProQuest) od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2000-01-01 do Před 1 rokem

Odkazy

PubMed 36068336
DOI 10.1038/s41388-022-02452-1
Knihovny.cz E-zdroje

Most of the organs of the digestive tract comprise secretory epithelia that require specialized molecular machines to achieve their functions. As such anterior gradient (AGR) proteins, which comprise AGR1, AGR2, and AGR3, belong to the protein disulfide isomerase family, and are involved in secretory and transmembrane protein biogenesis in the endoplasmic reticulum. They are generally expressed in epithelial cells with high levels in most of the digestive tract epithelia. To date, the vast majority of the reports concern AGR2, which has been shown to exhibit various subcellular localizations and exert pro-oncogenic functions. AGR2 overexpression has recently been associated with a poor prognosis in digestive cancers. AGR2 is also involved in epithelial homeostasis. Its deletion in mice results in severe diffuse gut inflammation, whereas in inflammatory bowel diseases, the secretion of AGR2 in the extracellular milieu participates in the reshaping of the cellular microenvironment. AGR2 thus plays a key role in inflammation and oncogenesis and may represent a therapeutic target of interest. In this review, we summarize the already known roles and mechanisms of action of the AGR family proteins in digestive diseases, their expression in the healthy digestive tract, and in digestive oncology. At last, we discuss the potential diagnostic and therapeutic implications underlying the biology of AGR proteins.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033170
003      
CZ-PrNML
005      
20230131151039.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41388-022-02452-1 $2 doi
035    __
$a (PubMed)36068336
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Boisteau, Emeric $u INSERM U1242, University of Rennes, Rennes, France $u Department of Gastroenterology, University Hospital Pontchaillou, University of Rennes, Rennes, France
245    10
$a Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology / $c E. Boisteau, C. Posseme, F. Di Modugno, J. Edeline, C. Coulouarn, R. Hrstka, A. Martisova, F. Delom, X. Treton, LA. Eriksson, E. Chevet, A. Lièvre, E. Ogier-Denis
520    9_
$a Most of the organs of the digestive tract comprise secretory epithelia that require specialized molecular machines to achieve their functions. As such anterior gradient (AGR) proteins, which comprise AGR1, AGR2, and AGR3, belong to the protein disulfide isomerase family, and are involved in secretory and transmembrane protein biogenesis in the endoplasmic reticulum. They are generally expressed in epithelial cells with high levels in most of the digestive tract epithelia. To date, the vast majority of the reports concern AGR2, which has been shown to exhibit various subcellular localizations and exert pro-oncogenic functions. AGR2 overexpression has recently been associated with a poor prognosis in digestive cancers. AGR2 is also involved in epithelial homeostasis. Its deletion in mice results in severe diffuse gut inflammation, whereas in inflammatory bowel diseases, the secretion of AGR2 in the extracellular milieu participates in the reshaping of the cellular microenvironment. AGR2 thus plays a key role in inflammation and oncogenesis and may represent a therapeutic target of interest. In this review, we summarize the already known roles and mechanisms of action of the AGR family proteins in digestive diseases, their expression in the healthy digestive tract, and in digestive oncology. At last, we discuss the potential diagnostic and therapeutic implications underlying the biology of AGR proteins.
650    _2
$a zvířata $7 D000818
650    _2
$a karcinogeneze $x genetika $7 D063646
650    12
$a gastrointestinální nádory $x genetika $7 D005770
650    _2
$a zánět $x genetika $7 D007249
650    _2
$a myši $7 D051379
650    _2
$a mukoproteiny $x genetika $7 D009088
650    12
$a onkogenní proteiny $x genetika $7 D015513
650    _2
$a proteindisulfidisomerasy $7 D019704
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Posseme, Céline $u INSERM U1242, University of Rennes, Rennes, France $u Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France
700    1_
$a Di Modugno, Federico $u INSERM U1242, University of Rennes, Rennes, France $u Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France $1 https://orcid.org/0000000182017997
700    1_
$a Edeline, Julien $u INSERM U1242, University of Rennes, Rennes, France $u Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France $1 https://orcid.org/0000000282897741
700    1_
$a Coulouarn, Cédric $u INSERM U1242, University of Rennes, Rennes, France $1 https://orcid.org/0000000256929586
700    1_
$a Hrstka, Roman $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $1 https://orcid.org/0000000261392664
700    1_
$a Martisova, Andrea $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000200810498
700    1_
$a Delom, Frédéric $u INSERM U1312, University of Bordeaux, Bordeaux, France
700    1_
$a Treton, Xavier $u Assistance Publique-Hôpitaux de Paris, University of Paris, Clichy, France
700    1_
$a Eriksson, Leif A $u Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden $1 https://orcid.org/0000000156543109
700    1_
$a Chevet, Eric $u INSERM U1242, University of Rennes, Rennes, France. eric.chevet@inserm.fr $u Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France. eric.chevet@inserm.fr $1 https://orcid.org/0000000158554522
700    1_
$a Lièvre, Astrid $u INSERM U1242, University of Rennes, Rennes, France. astrid.lievre@chu-rennes.fr $u Department of Gastroenterology, University Hospital Pontchaillou, University of Rennes, Rennes, France. astrid.lievre@chu-rennes.fr $1 https://orcid.org/000000032118717X
700    1_
$a Ogier-Denis, Eric $u INSERM U1242, University of Rennes, Rennes, France. eric.ogier-denis@inserm.fr $u Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France. eric.ogier-denis@inserm.fr $1 https://orcid.org/0000000200577593
773    0_
$w MED00003600 $t Oncogene $x 1476-5594 $g Roč. 41, č. 42 (2022), s. 4673-4685
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36068336 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151035 $b ABA008
999    __
$a ok $b bmc $g 1891751 $s 1184505
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 41 $c 42 $d 4673-4685 $e 20220906 $i 1476-5594 $m Oncogene $n Oncogene $x MED00003600
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace